SH QRQ GHVLGHUD SL ULFHYHUH O¶LQYLR GHOOD SUHVHQWH QHZVOHWWHU GL LQIRUPD]LRQH VFLHQWLILFD, FOLFFKL TXL . SH QRQ GHVLGHUD SL ULFHYHUH DOWUR PDWHULDOH LQIRUPDWLYR H SURPR]LRQDOH VXL SURGRWWL H VHUYL]L RIIHUWL GD EGUD S.S.A., OD SUHJKLDPR GL VHJXLUH OH LVWUX]LRQL IRUQLWH VXO VLWR IQWHUQHW JHVWLWR GD EGUD S.S.A. FOLFFDQGR VX TXHVWR OLQN . SL XWLOL]]HUj OD SLDWWDIRUPD SWUHDP\DUG FRQ SXEEOLFD]LRQH LQ GLUHWWD VX FDFHERRN, LLQNHGLQ, <RXTXEH. Ê SRVVLELOH SDUWHFLSDUH DOOD VHVVLRQH WUDPLWH TXDOVLDVL GLVSRVLWLYR. COME SEGUIRE IL WEBINAR ACCEDI ALLA DIRETTA CLICCANDO QUI CONCLUSIONI DRWW. MDUFR CRVVROR Presidente Federfarma QUESTION TIME VLdHR WXWRULaO SHU Oa SUaWLca HVHcX]LRQH dL XQ WHVW dLaJQRVWLcR LQ IaUPacLa H SURcHdXUH HVHcXWLYH DRWW. AOIUHGR PURFDFFLQL Titolare di Farmacia - Vice Presidente Federfarma DRWW. AOEHUWR D¶EUFROH Direttore Generale Federfarma PURILOL VWUXWWXUaOL-RUJaQL]]aWLYL H adHPSLPHQWL SHU OH IaUPacLH DRWW. AQWRQLR MDVWURLDQQL JLj Direttore Generale Fofi THVW dL OabRUaWRULR SHU Oa dLaJQRVL dL SaUV-CRV-2: aVSHWWL UHJROaWRUL, UHTXLVLWL SHU O¶LPPLVVLRQH LQ cRPPHUcLR, Oa dHWHQ]LRQH, O¶XWLOL]]R H Oa cHVVLRQH DRWW.VVD MDUFHOOD MDUOHWWD Esperto di sanitj pubblica, farmaci e dispositiYi medici Docente UniYersitj San Raffaele THVW dL OabRUaWRULR SHU Oa dLaJQRVL dL SaUV-CRV-2: WLSRORJLa, PHWRdLcKH H cULWHUL dL VcHOWa SHU XQ ORUR XVR Ua]LRQaOH DRWW.VVD PDROD SWHIDQHOOL Direttore Reparto malattie preYenibili da Yaccino Dipartimento Malattie InfettiYe Istituto Superiore di Sanitj COORDINAMENTO DEI LAVORI SHQ. DRWW. LXLJL D¶APEURVLR LHWWLHUL Presidente Fonda]ione CannaYz APERTURA DEI LAVORI OQ. DRWW. AQGUHD MDQGHOOL Presidente Fofi PURJUaPPa COVID-19 E TEST DIAGNOSTICI aVSHWWL VcLHQWLILcL, UHJROaWRUL H RSHUaWLYL VENERDI¶ 18 DICEMBRE 2020 RUH 14.30 - 16.30 WEBINAR CON TUTORAGGIO LD JUDYH HPHUJHQ]D SDQGHPLFD LQ DWWR H LO FUHVFHQWH QXPHUR GHL FRQWDJL LPSRQJRQR OD QHFHVVLWj GL XQD GLDJQRVL UDSLGD GHOO'LQIH]LRQH GD SDUWH GHO QXRYR FRURQDYLUXV SHU HYLWDUQH O¶XOWHULRUH GLIIXVLRQH DWWUDYHUVR LO FRQWHQLPHQWR GHL VRJJHWWL SRVLWLYL H XQD HIILFDFH DWWLYLWj GL FRQWDFW WUDFLQJ. IQ WDOH FRQWHVWR VL UHQGH QHFHVVDULR LQGLYLGXDUH OD WLSRORJLD GL WHVW GLDJQRVWLFR GD HVHJXLUH, WHQHQGR FRQWR GHOOH HYLGHQ]H VFLHQWLILFKH H GHO VRJJHWWR GD VRWWRSRUUH D FRQWUROOR (VRVSHWWR FOLQLFR, FRQWDWWR VWUHWWR, HWF). L¶HYHQWR LQWHQGH DSSURIRQGLUH JOL DVSHWWL VFLHQWLILFL UHODWLYL DOOD GLDJQRVWLFD GL SARS-CRV-2 H TXHOOL GL QDWXUD UHJRODWRULD FKH VWDELOLVFRQR L UHTXLVLWL FKH L WHVW GHYRQR SRVVHGHUH DL ILQL GHOO¶XVR H GHOOD FHVVLRQH. VHUUDQQR DOWUHVu HVDPLQDWL JOL DGHPSLPHQWL H L SURILOL WHFQLFR-VWUXWWXUDOL H RUJDQL]]DWLYL SUHYLVWL GD SURYYHGLPHQWL UHJLRQDOL SHU O¶HVHFX]LRQH GHL WHVW LQ FRQGL]LRQL GL HIILFDFLD H VLFXUH]]D GD SDUWH GHOOH IDUPDFLH. VENERDI’ 18 DICEMBRE 2020 ore 14.30 - 16.30 In collabora]ione con SX LQL]LDWLYD GL COVID-19 E TEST DIAGNOSTICI aspetti scientifici, regolatori e operativi SH QRQ YLVXDOL]]D FRUUHWWDPHQWH TXHVWR PHVVDJJLR, FOLFFKL TXL .